Abstract
In this issue of Blood, Miller and colleagues present data on the administration of haploidentical NK cells to cancer patients. They identify a feasible and safe method for in vivo NK cell expansion and clinical efficacy.
Cite
CITATION STYLE
APA
Velardi, A. (2005, April 15). NK cell adoptive immunotherapy. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2005-01-0322
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free